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Carcinoma of the head and neck is the 6th cause of death by cancer in the world. In recent decades 
the human papillomavirus (HPV) has been implicated in the etiology of this disease
Objective: To characterize the types of HPV detected in the oral mucosa in women with cytological 
abnormalities suggesting intraepithelial squamous lesions in the uterine cervix.
Methods: four-hundred-nine cervical-vaginal and oral pap-smears of women interned in a Female 
Prison in São Paulo were examined. The relationship between cervical and oral lesion was analyzed 
by PCR/RFLP and DNA sequencing.
Results: Of 27 (6.67%) specimens showing cervical cytological abnormalities suggesting LSIL and 
HSIL, 22 (81.48%) had oncogenic high-risk HPV infection, of which HPV 59 was the most prevalent. 
Three (11.1%) samples showed cytological changes suggesting mild dysplasia in the oral cavity.
Conclusion: Our study suggests an association between carcinoma of the oral cavity and HPV 
infection, regardless of the virus type.
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INTRODUCTION
Head and neck cancer is the 5th largest cause of 
cancer and the 6th largest cause of death by cancer 
in the world1. The largest incidence of this disease 
stems from the squamous cells of the upper digestive 
tract epithelium (oral cavity, pharynx and larynx). 
The main risk factors associated with the origin of 
this cancer are: smoking and alcoholism2.
Estimates for the year 2010 showed the occur-
rence of 14,120 new cases of oral cavity cancer, with 
a total of 6,214 cases of death caused by this disease, 
being the largest prevalence associated with males 
(10,330 cases)3.
In the last decades, infection by the Human 
Papilloma Virus (HPV) has been associated with the 
etiology of this disease, as it happens with uterine 
cervix cancer. It is believed that the oral infection 
may be acquired through oral or orogenital contact, 
or autoinfection. Sexual behavior has a direct rela-
tionship with the transmission mechanism of this 
viral infection, and the direct contact between the 
mucosae is the main route4-7. Vertical transmission 
can also happen8,9.
HPV is a DNA virus, epitheliotropic, non-
enveloped, with a double strand circular genome, 
and about 8,000 pb, measuring 55 nm in diameter. 
Its genome is broken down into three regions: a long 
control region (LCR) and the Early (E) and Late (L) 
regions. Regions E and L code viral proteins, while 
the LCR is called non-coding region10-12.
This virus’s oncogenic action is associated with 
the interaction of E6 and E7 oncoproteins, produced 
by the early genes E6 and E7, respectively. These 
proteins are involved in cell proliferation control, 
controlled by genes p53 and pRb, respectively, 
responsible for cell DNA control and correction, re-
sponsible for cell transformation and the malignant 
evolution of these lesions13-15.
HPV plays an important role in the oncogenesis 
of oral carcinoma, and its nomenclature is associated 
with its oncogenic potential. The pre-malignant le-
sions caused by the low-risk viruses are characterized 
by epithelial cells with nuclear atypias and cytoplas-
mic changes known as koilocyte, which have an 
enlarged nucleus, hyperchromia, perinuclear halo, 
binucleation or multinucleation and an increase in 
cytoplasm keratinization. These changes may also 
be found in high grade lesions, though less often16.
The low oncogenic risk viruses are: HPV-
6, HPV-11, HPV-42, HPV-43, HPV-44, HPV-54, 
HPV-61, HPV-70, HPV-72 and the HPV-81, which 
cause benign lesions, known as oral warts, pap-
illoma and white epithelium in the oral cav-
ity. The high oncogenic risk viruses are: HPV-16, 
HPV-18, HPV-31, HPV-33, HPV-45, HPV-51, HPV-
51, HPV-52, HPV-56, HPV-58, HPV-59, HPV-68, 
HPV-73 and the HPV-82. These are associated 
with atypical hyperplasia and oral carcinoma17,18. 
In these cases, HPV-16 has been more frequently 
found19-21.
The goal of this study was to do a molecular 
characterization of HPV types diagnosed in the oral 
mucosa of the women who had cytological changes 
matching those of a low grade squamous lesion and 
a high grade one in the uterine cervix.
MATERIALS AND METHODS
The present study is a cross-sectional con-
temporary cohort study, in which we studied 409 
cervix-vaginal and oral cavity samples from women 
aged between 18 and 60 years of age, sexually active, 
inmates of the Women’s Prison of the City of São 
Paulo, between February of 2006 and December of 
2007. Initially, the women were submitted to an inter-
view, aiming at obtaining clinical, sexual and social 
behavior information. The patients were instructed 
about and given the Informed Consent Form. This 
project was submitted to and approved by the Ethics 
in Research Committee of the Federal University of 
São Paulo (UNIFESP-CEP: 0369/06).
Biological material gathering
The biological material was gathered in two 
stages: (i) cervix-vaginal material gathering; (ii) oral 
material gathering. We carried out two gatherings 
from each one of the cavities (cervix-vaginal and 
oral). Initially, the gathering was carried out by the 
conventional method (REF) and fixed in the slide 
using Citofix®. Following that, we carried out an-
other gathering in the same region, using a brush 
with plastic bristles from the DNA-Citoloq® gathering 
kit, from Digene® - Brazil and it was preserved in a 
proprietary liquid medium, called UMC®. The same 
gathering procedure was utilized in order to gather 
material from the oral cavity21.
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Cytological analysis
The cytological samples gathered by the con-
ventional method were submitted to Papanicolau 
dye and analyzed under light microscopy at the Cy-
topathology Department of the Biomedicine Lab in 
São Leopoldo/”IN CITO” by two clinical examiners. 
The cell changes were classified according to the 
Bethesda 2001 system.
Molecular detection and characterization
The molecular characterization of the HPV 
types was carried out by the Polymerase Chain Re-
action (PCR), RFLP and the Sequencing methods at 
the Molecular Biology Department of the Clinical 
Microbiology Special Lab (LEMC) of the Infectology 
Program of the UNIFESP and the Molecular Biology 
Lab from AFIP3. The HPV-DNA was detected by PCR. 
The HPV-DNA was extracted using the GFX® kit (GE 
Healthcare) used to extract the genomic DNA of 
epithelial cells. The HPV-DNA was amplified using 
the MY9 and MY11 universal primers, which amplify 
the large majority of HPV types. The product of such 
amplification was submitted to RFLP techniques, 
according to the protocol proposed by Bernard et 
al.22 and sequenced by the Big Dye Terminator Cycle 
Sequencing kit (Applied Biosystems, Foster City, 
CA). We used the ABI PRISM 310, Genetic Analyzer 
(Applied Biosystems, Perkin Elmer, California). The 
DNA sequences obtained were analyzed using the 
Lasergene Software Package (DNASTAR, Madison, 
WI) and, following that, they were submitted to 
comparison with the genetic data base23,24.
RESULTS
Cytological analysis
Of the 409 cervix-vaginal samples gathered 
and assessed, 27 (6.67%) showed lesions in the uter-
ine cervix, according to the cyto-pathology report. 
Among the 27 women who had lesions in the uterine 
cervix, three (11.11%) showed cell changes associ-
ated with mild dysplasia in the oral cavity, with mild 
dyskariosis in mature squamous cells, and 24 (88.89) 
showed reactive changes associated with inflamma-
tion, occasionally associated with infectious agents 
(Table 1). Only the 27 women who had pre-malignant 
and malignant lesions of the uterine cervix were as-
sessed as to the presence of HPV in their oral cavities.
Molecular analysis
The 27 cervix-vaginal and oral cavity samples 
with cytology report suggestive of viral infection were 
confirmed as to the presence of HPV-DNA by PCR 
and characterized as to the type of HPV by the RFLP 
and sequencing methods.
Of the three samples which showed cell 
changes associated with mild oral cavity dysplasia, 
all (100%) had HPV-DNA, and one (33.33%) showed 
concurrent infections by HPV-16 and HPV-59; and 
these were the most prevalent types in the pre-
malignant lesions.
Among the 27 oral and cervix samples submit-
ted to molecular characterization, 18 (66.66%) had 
concurrent infection in both regions; nonetheless, 
only one sample (3.70%) had concurrent infections 
by the same type of virus, HPV-39 (Table 1).
Among the 27 samples gathered from the oral 
mucosa, 23 (85.18%) had HPV infection, 22 (81.48%) 
of those were caused by high oncogenic risk HPV, 
one sample (3.70%) was positive concerning the pres-
ence of HPV-DNA; nonetheless, it was not possible 
to characterize it in a molecular level. The largest 
prevalence of infection in women aged between 26 
and 35 years of age (44.44%) and the most preva-
lent type of HPV characterized was HPV59, in 11 
(40.75%) oral samples. Four (14.82%) samples did 
not have HPV infection. Two (7.41%) samples had 
two different types of HPV, one sample had HPV-16 
and HPV-18 and another sample had HPV-16 and 
HPV-59 (Table 2).
When we consider the sexual behavior of the 
27 inmates who had a positive result for oral cavity 
HPV, it was possible to notice that of the 27 positive 
samples for HPV, 18 (66.7%) samples , in which HPV 
infection was detected, were from women with het-
erosexual behavior. Three (11.11%) positive samples 
were identified in women with bisexual behavior. 
Two (7.41%) samples came from homosexual women 
(Table 3).
Among the 27 samples gathered from the 
oral cavity, 11 (40.75%) had a greater prevalence of 
HPV-59, two (7.40%) samples had HPV-16, and type 
16 was seen in two more cases of concurrent infec-
tions. One sample (3.70%) had HPV-18, concurrent 
HPV-16, three (11.11%) samples had HPV-39, five 
(18.53%) samples had HPV-58; and HPV–59 was the 
most prevalent (Table 4).
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Table 1. Comparative table between the cervix-vaginal and oral samples infected by HPV.
Uterine Cervix Oropharynx
N Cytology PCR/RFLP Cytology Sequencing % Similarity (GeneBank)
1 HSIL – NIC II HPV – 18 Negative Negative Not applicable
2 Inflammation/AGUS NEG Negative Negative Not applicable
3 ASC-US HPV-6b Negative Negative Not applicable
4 LSIL HPV – 6b Negative HPV-59 (90%)
5 ASC-US Negative Negative HPV-39 (98%)
6 LSIL HPV – 61 Mild dysplasia HPV-59 (88%)
7 ASC-US Negative Negative HPV-59 (93%)
8 LSIL HPV – 6b Negative HPV-59 (88%)
9 LSIL HPV – 6 b Negative NEG Not applicable
10 LSIL HPV – 39 Negative HPV-39 (97%)
11 LSIL HPV – 34 Negative HPV-59 (94%)
12 LSIL HPV – 31 Negative HPV-59 (92%)
13 LSIL HPV – 6b Negative HPV-59 (89%)
14 LSIL Negative Negative HPV59 (91%)
15 LSIL HPV – 16 Negative HPV59 (90%)
16 LSIL HPV – 6b Negative HPV59 (93%)
17 LSIL HPV – 6b Mild dysplasia HPV-16/59 (85/82%)
18 LSIL HPV – 6b Negative HPV-58 (96%)
19 ASC-US Negative Negative HPV-58 (99%)
20 ASC-US Negative Negative HPV-58 (89%)
21 LSIL HPV – 16 Negative HPV-58 (98%)
22 HSIL HPV – 16 Negative HPV39 (94%)
23 LSIL HPV – 6b Negative HPV-16 (82%)
24 LSIL HPV – 16 Negative HPV-58 (94%)
25 LSIL HPV – 6b Mild dysplasia HPV-16 (91%)
26 HSIL/NIC III HPV – 33 Negative HPV-16/18 (90%)
27 Invasive CA HPV – 18 Negative undefined Not applicable
LSIL: (Low-grade squamous intraepithelial lesion); ASC-US: (Squamous atypia of undetermined significance); Invasive CA: (Invasive squamous carcinoma).
Table 2. Prevalence of positive oral cavity samples for HPV-
-DNA identified by the sequencing method and classified by 
age range.
Age range 
(years)
HPV (+) HPV(-) Total
18 to 25 4 (14.82%) 0(0%) 5 (18.52%)
26 to 35 13 (48.14%) 3 (11.12) 15 (55.56)
36 to 45 6 (22.22) 0 6 (6.22)
46 to 55 0 1 (3.70%) 1 (3.70%)
Total 23 (81.48%) 4(14.82%) 27 (100%)
Table 3. Positiveness rate for HPV characterized by the mole-
cular sequencing in the samples of women classified according 
to sexual behavior.
Sexual 
orientation
HPV (+) HPV(-) Total
Heterosexual 18( 66.67%) 3 (11.11%) 21 (77.78%)
Bisexual 3 (11.11%) 0 (0%) 3 (11.11%)
Homosexual 2 (7.41%) 1 (3.70%) 3 (11.11%)
Total 23 (85.18%) 4 (14.82%) 27(100%)
Among the 27 oral samples from the molecularly 
characterized women, 18 (66.67%) reported smoking 
and nine (33.33%) said they did not smoke. Such habit 
was seen more frequently among women aged between 
26 and 35 years of age – 11 (40.74%) cases (Table 5).
Among the 18 smokers, 16 (59.26%) women 
were infected by HPB and two (7.40%) did not have 
HPV-DNA. Among the non-smoking women, seven 
(25.95%) had oral HPV infection and two (7.40%) 
of these women did not have oral viral infection 
(Table 6).
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Table 4. Prevalence of HPV types in oral samples gathered at 
the women’s prison of the city of São Paulo.
Type of HPV Samples Percentage (%)
Negative 4 14.81
HPV 16* 2* 7.40
HPV 18 1 3.70
HPV 39 3 11.11
HPV 58 5 18.53
HPV 59 11 40.75
Undefined 1 3.70
Total 27 100
* HPV 16 was found in two isolated samples and also in two samples 
with simultaneous infections.
Table 5. The table shows the occurrence rate of women 
smokers per age range.
SMOKER
YES NO
AGE GENERAL % GENERAL %
18-25 3 11.11% 1 3.70%
26-35 11 40.74% 4 14.81%
36-45 4 14.81% 2 7.41%
46-55 0 0.00% 2 7.41%
Total 18 66.66% 9 33.33%
Table 6. This table shows the occurrence of HPV infection and 
pre-malignant lesions in women smokers and non-smokers 
from the women’s prison of the city of São Paulo.
Samples HPV + HPV -
MILD 
DYSPLASIA
Smokers
18 
(66.66%)
16 
(59.26%)
2 (7.40%) 2 (7.40%)
Non-
-smokers
9 (33.34%) 7 (25.93%) 2 (7.40%) 1 (3.70%)
Total 27 (100%)
DISCUSSION
The relationship between HPV infection 
and lesions on the oral mucosa and oropharynx 
still is controversial. Numerous studies showed 
the HPV in the intact oral mucosa, and infected 
by the pre-malignant and malignant lesions; the 
tonsil area seems to be the area of the greatest 
penetration and cell transformation induced by the 
HPV. More sensitive molecular techniques, such as 
molecular characterization by sequencing, enable a 
better quality in the identification of the viral type 
in its infection site. Sexual behavior, associated or 
not to risk factors such as cigarette smoking and al-
cohol increase virus penetration in the oral mucosa, 
thus increasing the likelihood of pre-malignant and 
malignant lesions.
Studies showed the association between this 
infection and oral lesions and oral carcinoma, varying 
between 25% and 80% of high risk HPV prevalence in 
samples gathered from oral cavity lavage or brushed25.
Our study showed 81.48% of HPV in the oral mu-
cosa of women inmates of the women’s prison of the city 
of São Paulo who had concurrent infections and lesions 
in the uterine cervix, suggesting an internal transmission.
Rintala et al.26 reported 42% of HPV oral in-
fection in the mucosae of children, having a 10% 
persistence within a 3-year interval. The correlation 
with the genital infection was 36%. Our study sug-
gested a good correlation among the women who 
had uterine cervix infection; nonetheless, the similar-
ity between the viral types in the two sites was low, 
and only one patient had the same type of HPV in 
the oral cavity and uterine cervix, which suggested a 
low frequency of autoinfection. Saini et al.27 reported 
the occurrence of 5.71% of concurrent infection by 
the HPV in women who had uterine cervix cancer.
Beaudenon et al.28 had associated the occur-
rence of multiple infections by HPV types 13 and 32 in 
cases of focal epithelial hyperplasia in the oral cavity.
Our study found three oral samples which had 
pre-neoplastic cell changes, mild dysplasia and also 
infection by high-oncogenic risk HPV, and in one of 
them had concurrent infections by HPV types 16 and 59.
Insofar as the age range is concerned, we 
found a higher frequency of HPV in the oral cavities 
of women between 20 and 30 years of age, mean 
age of 25 years, encompassing 40.74% of infection 
cases. Smith et al.29 found 47.10% of HPV infection 
in women with the mean age of 24 years.
The study showed a greater prevalence of HPV-
59, and in two cases there was oral dysplasia and 
one case of multiple infections associated with the 
HPV 16. Kreimer et al.30 found a greater prevalence 
of HPV-16 in samples obtained from the oral cavity 
lavage in HIV-positive patients; HPV 58 and 59 were 
found in a lesser frequency. Hanson et al.31 found 
HPV-16 and HPV-59 infections in samples obtained 
from the oral cavity lavage of patients with oral and 
oropharynx cancer in Sweden.
Hennessey et al.32 reported the presence of 
infections by HPV-58 and 59 in pre-malignant and 
malignant lesions in the oral cavity and suggested 
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that these types of viruses have a high oncogenic 
potential for the development of neoplasia in the 
oropharynx mucosa.
The greater rate of HPV oral infection hap-
pened to heterosexual women, showing, in this case, 
that the deviation in behavior does not have any 
direct relation to the viral transmission mechanism. 
Our results corroborate the findings from D’Souza 
et al.33, who found a greater occurrence of HPV oral 
infection in heterosexual women; nonetheless, they 
found a low prevalence of infections in smoking 
women. Xavier et al.34 found a greater occurrence of 
HPV oral infection in heterosexual and monogamist 
men; nonetheless, the prevalence of oral infection 
was found in one case only.
During a fair amount of time, cigarette 
smoking and alcohol ingestion were consid-
ered the main cofactors in the occurrence of 
oral cavity and oropharynx lesions. Today, it is 
believed that the HPV plays an important role 
in the development of these lesions. Our study 
showed that 66.66% of the women, prison inmates, 
were smokers; among them, 59.26% were infected 
by the high risk HPV. Studies have shown an as-
sociation between 0 and 55% of HPV infection in 
smokers. It is believed that this risk factor causes 
sequential repairs to the oral mucosa, making it 
more susceptible for viral infection. Chen et al.35, 
studied tissues through in situ hybridization, and 
found 78% of high risk HPV infection in smokers 
with squamous papilloma.
Thus, following up the inmates of the women’s 
prison of the city of São Paulo by means of preven-
tive gynecological exams and clinical and molecular 
evaluation of the oral cavity may clarify the possible 
relationship between HPV infection and oral cavity 
lesions in women who have simultaneous infection 
of the female genital tract.
CONCLUSION
According to our study, we may suggest the 
existence of an association between the development 
of oral cavity lesions and HPV infection; however, it 
did not show a direct association between the types 
of viruses present in the uterine cervix and in the oral 
cavity, and still a weak association with the sexual 
behavior of the inmates of the women’s prison of 
the city of São Paulo.
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